There are 2 different but related issues here–
–did the DVM adhere to regulations on prescribing/dispensing prescription medication, particularly with respect to ELUD? This would likely be a matter which could be filed as a complaint with the board of registration of veterinary medicine in the state where the activity took place.
–Baffert seems to be indicating that the DVM did not mention any potential issues with said medication, and that failure may have cost him a race and substantial financial resources, given all the hearings, suspensions, etc.
He might very well file suit against the DVM for that–the DVM, as a professional licensed to prescribe drugs should theoretically be held to a higher standard than the trainer or owner to whom the drugs were provided, and any failure to note potential positives could be seen as negligent.
And just how would they have such information unless provided by the prescriber of such treatment?
There should be, which is why I’m curious as to whether there was.
All we have thus far is allegations from Baffert.
IANAL, so I don’t know whether hearsay is admissible in the hearings.
It isn’t applied with a trowel. A little goes a long way.
That size is intended for use in dispensing smaller quantities into containers–something the pharmacist or DVM would keep on the shelf.
On what basis do you make such a claim?
It’s licensed/approved for the treatment of chronic otitis media in dogs. But it is a fairly shotgun recipe for skin funk. I could see why it might be used to treat same.
The questions here are:
was it being used for that purpose?
If so, was it prescribed, or did Baffert and company have it on hand and made the decision to use it?
Or was it employed after the fact as a convenient excuse to explain the presence of betamethasone?
If it was prescribed, was Baffert informed/cautioned about the presence of betamethasone in the medication?
We don’t have much in the way of answers yet.